These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 20965961

  • 1. Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology.
    Laule C, Vavasour IM, Leung E, Li DK, Kozlowski P, Traboulsee AL, Oger J, Mackay AL, Moore GR.
    Mult Scler; 2011 Feb; 17(2):144-50. PubMed ID: 20965961
    [Abstract] [Full Text] [Related]

  • 2. Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
    Laule C, Pavlova V, Leung E, Zhao G, MacKay AL, Kozlowski P, Traboulsee AL, Li DK, Moore GR.
    J Neuropathol Exp Neurol; 2013 Jan; 72(1):42-52. PubMed ID: 23242281
    [Abstract] [Full Text] [Related]

  • 3. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [Abstract] [Full Text] [Related]

  • 4. Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss.
    Moore GR, Laule C, Mackay A, Leung E, Li DK, Zhao G, Traboulsee AL, Paty DW.
    J Neurol; 2008 Nov; 255(11):1802-11. PubMed ID: 18821049
    [Abstract] [Full Text] [Related]

  • 5. Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
    Zhang Y, Moore GR, Laule C, Bjarnason TA, Kozlowski P, Traboulsee A, Li DK.
    Ann Neurol; 2013 Jul; 74(1):91-9. PubMed ID: 23939554
    [Abstract] [Full Text] [Related]

  • 6. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH.
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [Abstract] [Full Text] [Related]

  • 7. Multislice brain myelin water fractions at 3T in multiple sclerosis.
    Oh J, Han ET, Lee MC, Nelson SJ, Pelletier D.
    J Neuroimaging; 2007 Apr; 17(2):156-63. PubMed ID: 17441837
    [Abstract] [Full Text] [Related]

  • 8. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 9. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 10. Diffusely Abnormal White Matter, T2 Burden of Disease, and Brain Volume in Relapsing-Remitting Multiple Sclerosis.
    Vertinsky AT, Li DKB, Vavasour IM, Miropolsky V, Zhao G, Zhao Y, Riddehough A, Moore GRW, Traboulsee A, Laule C.
    J Neuroimaging; 2019 Jan; 29(1):151-159. PubMed ID: 30376195
    [Abstract] [Full Text] [Related]

  • 11. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 12. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier.
    Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD.
    Ann Neurol; 1993 Sep; 34(3):339-50. PubMed ID: 7689819
    [Abstract] [Full Text] [Related]

  • 13. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 14. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [Abstract] [Full Text] [Related]

  • 15. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study.
    Laule C, Vavasour IM, Moore GR, Oger J, Li DK, Paty DW, MacKay AL.
    J Neurol; 2004 Mar; 251(3):284-93. PubMed ID: 15015007
    [Abstract] [Full Text] [Related]

  • 16. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS, Cardoso MJ, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ron M, Ourselin S, Miller DH, Chard DT.
    Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
    [Abstract] [Full Text] [Related]

  • 17. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance.
    Papadaki E, Mastorodemos V, Panou T, Pouli S, Spyridaki E, Kavroulakis E, Kalaitzakis G, Maris TG, Simos P.
    J Magn Reson Imaging; 2021 Oct; 54(4):1077-1087. PubMed ID: 33960066
    [Abstract] [Full Text] [Related]

  • 18. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C, Charil A, Caputo D, Cavarretta R, Sormani MP, Filippi M.
    Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
    [Abstract] [Full Text] [Related]

  • 19. Insights into brain microstructure from the T2 distribution.
    MacKay A, Laule C, Vavasour I, Bjarnason T, Kolind S, Mädler B.
    Magn Reson Imaging; 2006 May; 24(4):515-25. PubMed ID: 16677958
    [Abstract] [Full Text] [Related]

  • 20. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
    Caramanos Z, DiMaio S, Narayanan S, Lapierre Y, Arnold DL.
    J Neurol Sci; 2009 Jul 15; 282(1-2):72-9. PubMed ID: 19232641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.